A new test in development may be able to detect both COVID-19 and the flu at the same time. Continuing Coverage: Coronavirus in Wisconsin"It's a test that simultaneously looks for influenza and the ...
QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...
Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex ...
(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...
Aug. 15 (UPI) --The U.S. Food and Drug Administration has issued an Emergency Use Authorization for the first multiplex test for the Zika virus and three other viruses. The FDA made the authorization ...
“We are excited to expand our infectious disease portfolio into the respiratory market,” said Colin Denver, SpeeDx CEO. “SpeeDx patented technology enables multiple targets to be easily combined into ...
SYDNEY — SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the Australian 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback